Transdermal Bioavailability
Transdermal Bioavailability is the fraction and rate of a drug absorbed through the skin into the systemic circulation following transdermal administration, distinguishing it from other route-dependent bioavailability measures by its specific dependence on dermal permeation kinetics and cutaneous barrier properties.
630
Publications
28.5K
Citations
2.4K
Authors
730
Institutions
Publications per year
2017–2026
161
630
Andreia Ascenso, Cátia Batista, Pedro J. S. Cardoso et al. · International Journal of Nanomedicine · 2015 · 371 citations · Full text
Absorption Characteristics of Transdermally Administered Fentanyl
John R. Varvel, Steven L. Shafer, Stephen S. Hwang et al. · Anesthesiology · 1989 · 354 citations · Full text
1–5 of 630
2.4K
8
h-index
7
h-index
6
h-index
6
h-index
6
h-index
1–5 of 2.4K
730

Cairo University
Giza, Egypt
11 h-index
30 publications
1.2K citations
Jamia Hamdard
New Delhi, India
11 h-index
41 publications
2.5K citations
Shenyang Pharmaceutical University
Shenyang, China
9 h-index
42 publications
1.4K citations
Rutgers, The State University of New Jersey
New Brunswick, United States
8 h-index
18 publications
931 citations
Novartis (Switzerland)
Basel, Switzerland
8 h-index
28 publications
906 citations
Universitat de València
Valencia, Spain
8 h-index
18 publications
391 citations

The University of Queensland
Brisbane, Australia
8 h-index
17 publications
650 citations
University of Michigan
Ann Arbor, United States
8 h-index
14 publications
799 citations
1–8 of 730
68 publications · 3.6K citations
37
h-index
20 publications · 1.1K citations
20
h-index
30 publications · 1.5K citations
20
h-index
25 publications · 1.2K citations
19
h-index
EJPB · 17 publications · 905 citations
17
h-index
1–5